Objective: ABI is a good predictor of morbidity and mortality in diabetic subjects with no known cardiovascular disease. However, its prognostic value in diabetic patients with prior coronary or cerebrovascular disease has not previously been evaluated.
Methods: Multicenter, prospective study of 1 year of follow-up, in 1096 patients (73.